協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/25 | 2,267 | 2,270 | 2,247 | 2,247 | -26 | -1.1% | 722,800 |
2018/05/24 | 2,290 | 2,300 | 2,263 | 2,273 | -2 | -0.1% | 845,800 |
2018/05/23 | 2,269 | 2,299 | 2,259 | 2,275 | -12 | -0.5% | 927,600 |
2018/05/22 | 2,285 | 2,297 | 2,264 | 2,287 | -6 | -0.3% | 639,200 |
2018/05/21 | 2,273 | 2,306 | 2,269 | 2,293 | +5 | +0.2% | 700,400 |
2018/05/18 | 2,266 | 2,298 | 2,251 | 2,288 | +23 | +1% | 1,048,700 |
2018/05/17 | 2,258 | 2,273 | 2,241 | 2,265 | +41 | +1.8% | 968,500 |
2018/05/16 | 2,208 | 2,237 | 2,201 | 2,224 | +13 | +0.6% | 878,400 |
2018/05/15 | 2,221 | 2,228 | 2,205 | 2,211 | -12 | -0.5% | 879,300 |
2018/05/14 | 2,234 | 2,238 | 2,209 | 2,223 | +18 | +0.8% | 830,700 |
2018/05/11 | 2,238 | 2,243 | 2,193 | 2,205 | -27 | -1.2% | 1,237,400 |
2018/05/10 | 2,244 | 2,259 | 2,195 | 2,232 | -14 | -0.6% | 1,183,800 |
2018/05/09 | 2,271 | 2,280 | 2,206 | 2,246 | -92 | -3.9% | 1,738,100 |
2018/05/08 | 2,317 | 2,349 | 2,316 | 2,338 | +5 | +0.2% | 913,400 |
2018/05/07 | 2,342 | 2,344 | 2,306 | 2,333 | -8 | -0.3% | 982,500 |
2018/05/02 | 2,349 | 2,351 | 2,303 | 2,341 | -11 | -0.5% | 948,200 |
2018/05/01 | 2,350 | 2,380 | 2,342 | 2,352 | -22 | -0.9% | 939,100 |
2018/04/27 | 2,377 | 2,400 | 2,369 | 2,374 | +15 | +0.6% | 946,100 |
2018/04/26 | 2,372 | 2,373 | 2,341 | 2,359 | -8 | -0.3% | 887,900 |
2018/04/25 | 2,365 | 2,382 | 2,356 | 2,367 | +2 | +0.1% | 832,700 |
2018/04/24 | 2,377 | 2,394 | 2,351 | 2,365 | +30 | +1.3% | 927,900 |
2018/04/23 | 2,377 | 2,381 | 2,332 | 2,335 | -38 | -1.6% | 818,500 |
2018/04/20 | 2,379 | 2,396 | 2,362 | 2,373 | -3 | -0.1% | 810,800 |
2018/04/19 | 2,376 | 2,420 | 2,365 | 2,376 | +12 | +0.5% | 1,321,000 |
2018/04/18 | 2,360 | 2,408 | 2,339 | 2,364 | +12 | +0.5% | 1,472,700 |
2018/04/17 | 2,393 | 2,402 | 2,345 | 2,352 | -66 | -2.7% | 923,100 |
2018/04/16 | 2,402 | 2,421 | 2,389 | 2,418 | +44 | +1.9% | 628,300 |
2018/04/13 | 2,405 | 2,444 | 2,362 | 2,374 | +17 | +0.7% | 1,281,600 |
2018/04/12 | 2,347 | 2,383 | 2,347 | 2,357 | +19 | +0.8% | 985,100 |
2018/04/11 | 2,392 | 2,398 | 2,316 | 2,338 | -72 | -3% | 1,198,600 |
2018/04/10 | 2,462 | 2,478 | 2,404 | 2,410 | -38 | -1.6% | 1,383,600 |
2018/04/09 | 2,443 | 2,471 | 2,418 | 2,448 | +4 | +0.2% | 1,233,000 |
2018/04/06 | 2,442 | 2,464 | 2,416 | 2,444 | -17 | -0.7% | 1,743,100 |
2018/04/05 | 2,415 | 2,475 | 2,400 | 2,461 | +80 | +3.4% | 1,788,400 |
2018/04/04 | 2,347 | 2,392 | 2,341 | 2,381 | +50 | +2.1% | 1,917,900 |
2018/04/03 | 2,250 | 2,340 | 2,237 | 2,331 | +55 | +2.4% | 1,735,500 |
2018/04/02 | 2,326 | 2,330 | 2,275 | 2,276 | -61 | -2.6% | 914,400 |
2018/03/30 | 2,316 | 2,364 | 2,312 | 2,337 | +50 | +2.2% | 1,557,400 |
2018/03/29 | 2,271 | 2,324 | 2,266 | 2,287 | +40 | +1.8% | 1,517,400 |
2018/03/28 | 2,217 | 2,251 | 2,207 | 2,247 | +3 | +0.1% | 1,037,500 |
2018/03/27 | 2,201 | 2,256 | 2,193 | 2,244 | +73 | +3.4% | 1,488,100 |
2018/03/26 | 2,125 | 2,173 | 2,124 | 2,171 | +20 | +0.9% | 1,143,000 |
2018/03/23 | 2,185 | 2,217 | 2,145 | 2,151 | -106 | -4.7% | 2,273,000 |
2018/03/22 | 2,220 | 2,266 | 2,215 | 2,257 | +25 | +1.1% | 1,013,200 |
2018/03/20 | 2,219 | 2,240 | 2,209 | 2,232 | ±0 | ±0% | 1,056,100 |
2018/03/19 | 2,242 | 2,247 | 2,201 | 2,232 | -32 | -1.4% | 1,051,200 |
2018/03/16 | 2,271 | 2,280 | 2,235 | 2,264 | +18 | +0.8% | 1,677,800 |
2018/03/15 | 2,242 | 2,250 | 2,215 | 2,246 | -5 | -0.2% | 777,900 |
2018/03/14 | 2,218 | 2,254 | 2,216 | 2,251 | +19 | +0.9% | 1,180,800 |
2018/03/13 | 2,185 | 2,232 | 2,184 | 2,232 | +22 | +1% | 830,700 |
1701~
1750
件表示中 / 3699件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 217,200円 | -3.5% | -11.3% | 2.76% | 19.95倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 134,100円 | +0.9% | +380.2% | 5.82% | 18.47倍 | 1.59倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 218,800円 | +20.9% | +10.6% | 3.02% | 10.34倍 | 1.37倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 366,700円 | +1.7% | -2.9% | 4.36% | 24.06倍 | 1.26倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 149,200円 | +0.6% | +43.3% | 5.36% | 10.46倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム